The global childhood absence epilepsy treatment market is expected to showcase significant growth from 2022 to 2030, with a positive outlook driven by several key factors. The market is projected to grow from USD 220.43 million in 2022 to USD 390.14 million by 2030, reflecting a robust CAGR during the forecast period. This growth can be attributed to increasing awareness about childhood absence...